Estimates of exposure to PM2.5 are often derived from geographic characteristics based on land-use regression or from a limited number of fixed ground monitors. Remote sensing advances have integrated these approaches with satellite-based measures of aerosol optical depth (AOD), which is spatially and temporally resolved, allowing greater coverage for PM2.5 estimations. Israel is situated in a complex geo-climatic region with contrasting geographic and weather patterns, including both dark and bright surfaces within a relatively small area. Our goal was to examine the use of MODIS-based MAIAC data in Israel, and to explore the reliability of predicted PM2.5 and PM10 at a high spatiotemporal resolution. We applied a three stage process, including a daily calibration method based on a mixed effects model, to predict ground PM2.5 and PM10 over Israel. We later constructed daily predictions across Israel for 2003–2013 using spatial and temporal smoothing, to estimate AOD when satellite data were missing. Good model performance was achieved, with out-of-sample cross validation R2 values of 0.79 and 0.72 for PM10 and PM2.5, respectively. Model predictions had little bias, with cross-validated slopes (predicted vs. observed) of 0.99 for both the PM2.5 and PM10 models. To our knowledge, this is the first study that utilizes high resolution 1km MAIAC AOD retrievals for PM prediction while accounting for geo-climate complexities, such as experienced in Israel. This novel model allowed the reconstruction of long- and short-term spatially resolved exposure to PM2.5 and PM10 in Israel, which could be used in the future for epidemiological studies.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.